| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.1M | +101.4% |
| R&D Expense | $25.9M | -29.8% |
| SG&A Expense | $7.2M | -2.0% |
| Operating Income | -$30.0M | +29.8% |
| Net Income | -$30.4M | +28.0% |
| EPS (Basic) | -$1.62 | +57.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.9M | -73.1% |
| Accounts Receivable | $1.0M | — |
| Current Assets | $11.6M | -52.3% |
| Total Assets | $14.7M | -45.2% |
| Current Liabilities | $36.9M | +10.6% |
| Total Liabilities | $38.9M | -2.5% |
| Stockholders' Equity | -$24.2M | -84.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.1M | -27.0% |
| Capital Expenditures | $82K | -84.5% |
| Investing Cash Flow | -$82K | +84.5% |
| Financing Cash Flow | $14.8M | -57.4% |
| Free Cash Flow | -$29.2M | -24.5% |